Plus   Neg

Myriad Genetics Inc. Q1 adjusted earnings Beat Estimates

Myriad Genetics Inc. (MYGN) announced earnings for its first quarter that increased from last year.

The company's earnings totaled $11.4 million, or $0.16 per share. This compares with $4.2 million, or $0.06 per share, in last year's first quarter.

Excluding items, Myriad Genetics Inc. reported adjusted earnings of $22.3 million or $0.31 per share for the period.

Analysts had expected the company to earn $0.27 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 1.7% to $193.5 million from $196.9 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q1): $22.3 Mln. vs. $18.1 Mln. last year.
-EPS (Q1): $0.31 vs. $0.27 last year.
-Analysts Estimate: $0.27
-Revenue (Q1): $193.5 Mln vs. $196.9 Mln last year.

Full year EPS guidance: $1.19 - $1.21
Full year revenue guidance: $771 Mln -$773Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT